BCDA: BioCardia, Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 10.11
Enterprise Value ($M) 9.00
Book Value ($M) -1.60
Book Value / Share -0.06
Price / Book -6.31
NCAV ($M) -3.13
NCAV / Share -0.12
Price / NCAV -3.23

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -1.62
Return on Equity (ROE) -6.09

Liquidity (mrq)
Quick Ratio 0.40
Current Ratio 0.40

Balance Sheet (mrq) ($M)
Current Assets 1.46
Assets 2.99
Liabilities 4.59
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.48
Operating Income -11.64
Net Income -11.57
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -9.97
Cash from Investing -0.01
Cash from Financing 3.73

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
04-05 13D/A Frost Gamma Investments Trust 4.80 -18.12
02-14 13G/A Satterfield Thomas A Jr 7.87 49.26
02-02 13G/A Francis Capital Management, LLC 0.00 -100.00
05-25 13D Daly Joseph Patrick 3.75 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-02 16,611 202,661 8.20
2024-05-01 116,525 118,535 98.30
2024-04-30 33,857 10,668 317.37
2024-04-29 15,775 7,630 206.75

(click for more detail)

Similar Companies
AVTX – Avalo Therapeutics, Inc. AWH – Aspira Women's Health Inc.
AYTU – Aytu BioPharma, Inc. BCLI – Brainstorm Cell Therapeutics Inc.
BCTX – BriaCell Therapeutics Corp.


Financial data and stock pages provided by
Fintel.io